Biogen (BIIB) Falls After Cautious Comments During Jefferies Call - Bloomberg
- Nasdaq, S&P stumble as Netflix, chip stocks drag; AmEx boosts Dow
- Sony/Apollo bid for Paramount could be worth as much as $29 billion - Source
- Netflix Q1 earnings top estimates on blowout subscriber growth
- Wall St indexes split, Treasuries dip amid earnings, geopolitical crosscurrents
- Gold prices rally past $2,400 on reports of Israel strikes on Iran
- Tritium DCFC Limited (DCFC): Three Australian subsidiaries were determined to be insolvent or likely to become insolvent
- Hasbro (HAS) Announces Resignation of Cynthia Williams, President of Wizards of the Coast and Hasbro Gaming
- Frontier Communications (FYBR) says third party had gained unauthorized access to portions of its information technology environment
- Jabil falls after placing CEO on paid leave amid internal investigation
- Ibotta (IBTA) Prices 6.56M Share IPO at $88/sh
- Midday movers: Netflix, Super Micro fall; Paramount Global gains
- After-hours movers: Netflix, Intuitive Surgical, Nordstrom, KB Home
- Midday movers: Tesla, Blackstone, Las Vegas Sands fall; DR Horton rises
- After-hours movers: Alcoa rises; Equifax and Las Vegas Sands fall
- Midday movers: Travelers, JB Hunt fall; United Airlines rises
FDA: No Change in Role of Neuroscience Director Billy Dunn - Bloomberg, Citing FDA Statement
March 15, 2021 5:40 PM EDTFDA: No Change in Role of Neuroscience Director Billy Dunn - Bloomberg, Citing FDA Statement
... MoreBiogen (BIIB) Comments to Truist Analyst About Billy Dunn
March 15, 2021 5:17 PM EDTTruist Research analyst Robyn Karnauskas asked Biogen (NASDAQ: BIIB) two questions related to Billy Dunn and received a response from mangaement.
1) is Billy Dunn still at FDA?
As far as mgmt knows, Billy Dunn is still listed as Director of... MoreBiogen (BIIB) sinks 5% intra-day
March 15, 2021 1:29 PM EDTBiogen (NASDAQ: BIIB) sinks 5% intra-day
... More